![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
Citations (67)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Fahad S Alshehri. (2023) Tapentadol: A Review of Experimental Pharmacology Studies, Clinical Trials, and Recent Findings. Drug Design, Development and Therapy 17, pages 851-861.
Read now
Read now
Filippo Migliorini, Nicola Maffulli, Alice Baroncini, Jörg Eschweiler, Markus Tingart & Valentin Quack. (2021) Opioids for chronic low back pain management: a Bayesian network meta-analysis. Expert Review of Clinical Pharmacology 14:5, pages 635-641.
Read now
Read now
Flaminia Coluzzi, Joseph V. Pergolizzi$suffix/text()$suffix/text(), Enrico Giordan, Pamela Locarini, Alessandro Boaro & Domenico Billeci. (2020) Tapentadol prolonged release for managing moderate to severe chronic neck pain with or without a neuropathic component. Current Medical Research and Opinion 36:4, pages 651-659.
Read now
Read now
Ulderico Freo, Patrizia Romualdi & Hans G Kress. (2019) Tapentadol for neuropathic pain: a review of clinical studies. Journal of Pain Research 12, pages 1537-1551.
Read now
Read now
Domenico Billeci & Flaminia Coluzzi. (2017) Tapentadol extended release for the management of chronic neck pain. Journal of Pain Research 10, pages 495-505.
Read now
Read now
Rainer Freynhagen, Thomas R. Tölle, Ulrich Gockel & Ralf Baron. (2016) The painDETECT project – far more than a screening tool on neuropathic pain. Current Medical Research and Opinion 32:6, pages 1033-1057.
Read now
Read now
Artur Schikowski, Doris Krings & Karla Schwenke. (2015) Tapentadol prolonged release for severe chronic cancer-related pain: effectiveness, tolerability, and influence on quality of life of the patients. Journal of Pain Research 8, pages 1-8.
Read now
Read now
Nebojsa Nick Knezevic, Tatiana Tverdohleb, Ivana Knezevic & Kenneth D Candido. (2015) Unique pharmacology of tapentadol for treating acute and chronic pain. Expert Opinion on Drug Metabolism & Toxicology 11:9, pages 1475-1492.
Read now
Read now
Howard S. Smith, Robert B. Raffa, Joseph V. Pergolizzi, Robert Taylor & Ronald J. Tallarida. (2014) Combining Opioid and Adrenergic Mechanisms for Chronic Pain. Postgraduate Medicine 126:4, pages 98-114.
Read now
Read now
A. Schwittay, C. Schumann, B. C. Litzenburger & K. Schwenke. (2013) Tapentadol Prolonged Release for Severe Chronic Pain: Results of a Noninterventional Study Involving General Practitioners and Internists. Journal of Pain & Palliative Care Pharmacotherapy 27:3, pages 225-234.
Read now
Read now
Articles from other publishers (57)
Eva Widerström-Noga. (2023) Neuropathic Pain and Spinal Cord Injury: Management, Phenotypes, and Biomarkers. Drugs 83:11, pages 1001-1025.
Crossref
Crossref
Harriet I. Kemp, Jan Vollert, Nicholas W.S. Davies, Graeme J. Moyle & Andrew S.C. Rice. (2023) A Comparison of Self-reported Pain Measures Between Sensory Phenotypes in HIV-associated Sensory Neuropathy. The Journal of Pain 24:1, pages 112-127.
Crossref
Crossref
Linda E. Robayo, Varan Govind, Roberta Vastano, Elizabeth R. Felix, Loriann Fleming, Nicholas P. Cherup & Eva Widerström-Noga. (2022) Multidimensional pain phenotypes after Traumatic Brain Injury. Frontiers in Pain Research 3.
Crossref
Crossref
Jonathan L. Fu & Michael D. Perloff. (2022) Pharmacotherapy for Spine-Related Pain in Older Adults. Drugs & Aging 39:7, pages 523-550.
Crossref
Crossref
Joseph Pergolizzi, Peter Magnusson, Flaminia Coluzzi, Frank Breve, Jo Ann K LeQuang & Giustino Varrassi. (2022) Multimechanistic Single-Entity Combinations for Chronic Pain Control: A Narrative Review. Cureus.
Crossref
Crossref
Michael A Überall, Christian Elling, Christoph Eibl, Gerhard HH Müller-Schwefe, Claudia Lefeber, Myriam Heine & Birgit Heckes. (2022) Tapentadol prolonged release in patients with chronic low back pain: real-world data from the German Pain eRegistry. Pain Management 12:2, pages 211-227.
Crossref
Crossref
Robert S. Ackerman, Patrick B. Ahern, Biral T. Patel & Carl E. Noe. 2022. Multidisciplinary Spine Care. Multidisciplinary Spine Care
121
136
.
Stella Iacovides, Peter Kamerman, Fiona C Baker & Duncan Mitchell. 2011. Comprehensive Physiology. Comprehensive Physiology
2589
2619
.
Jitka FRICOVÁ, Helena LAINCZOVÁ, J NEDVÍDEK & R ROKYTA. (2021) Effect of Tapentadol on Experimental Model of Orofacial Pain – a Pilot Study. Physiological Research, pages S533-S537.
Crossref
Crossref
Robert R. Edwards, Robert H. Dworkin, Dennis C. Turk, Martin S. Angst, Raymond Dionne, Roy Freeman, Per Hansson, Simon Haroutounian, Lars Arendt-Nielsen, Nadine Attal, Ralf Baron, Joanna Brell, Shay Bujanover, Laurie B. Burke, Daniel Carr, Amy S. Chappell, Penney Cowan, Mila Etropolski, Roger B. Fillingim, Jennifer S. Gewandter, Nathaniel P. Katz, Ernest A. Kopecky, John D. Markman, George Nomikos, Linda Porter, Bob A. Rappaport, Andrew S.C. Rice, Joseph M. Scavone, Joachim Scholz, Lee S. Simon, Shannon M. Smith, Jeffrey Tobias, Tina Tockarshewsky, Christine Veasley, Mark Versavel, Ajay D. Wasan, Warren Wen & David Yarnitsky. (2021) Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations. PAIN Reports 6:1, pages e896.
Crossref
Crossref
Gabriele Finco, Maurizio Evangelista & Salvatore Sardo. (2020) Basic guide to chronic pain assessment: from neurophysiology to bedside. Minerva Anestesiologica 86:12.
Crossref
Crossref
Jan C. Otto, Julia Forstenpointner, Juliane Sachau, Philipp Hüllemann, Martin Hukauf, Thomas Keller, Janne Gierthmühlen & Ralf Baron. (2019) A Novel Algorithm to Identify Predictors of Treatment Response: Tapentadol Monotherapy or Tapentadol/Pregabalin Combination Therapy in Chronic Low Back Pain?. Frontiers in Neurology 10.
Crossref
Crossref
Julia Forstenpointner, Stefanie Rehm, Janne Gierthmühlen & Ralf Baron. (2018) Stratification of neuropathic pain patients. Current Opinion in Anaesthesiology 31:5, pages 562-568.
Crossref
Crossref
Robert B. Raffa, Christian Elling & Thomas M. Tzschentke. (2018) Does ‘Strong Analgesic’ Equal ‘Strong Opioid’? Tapentadol and the Concept of ‘µ-Load’. Advances in Therapy 35:10, pages 1471-1484.
Crossref
Crossref
Jessie S Channell & Stephan Schug. (2018) Toxicity of tapentadol: a systematic review. Pain Management 8:5, pages 327-339.
Crossref
Crossref
R. Vellucci, R. Terenzi, J. A Kanis, H. G. Kress, R. D. Mediati, J.-Y. Reginster, R. Rizzoli & M. L. Brandi. (2018) Understanding osteoporotic pain and its pharmacological treatment. Osteoporosis International 29:7, pages 1477-1491.
Crossref
Crossref
Joseph V. PergolizziJrJr, Robert TaylorJrJr, Jo Ann LeQuang, Robert B. Raffa & John Bisney. (2018) Tapentadol Extended Release in the Treatment of Severe Chronic Low Back Pain and Osteoarthritis Pain. Pain and Therapy 7:1, pages 37-57.
Crossref
Crossref
Ulf Schutter. (2018) Rückenschmerzen — Sichere Schmerztherapie in Klinik und Praxis. Schmerzmedizin 34:3, pages 28-31.
Crossref
Crossref
Julia Forstenpointner, Jan Otto & Ralf Baron. (2017) Individualized neuropathic pain therapy based on phenotyping: are we there yet?. Pain 159:3, pages 569-575.
Crossref
Crossref
L. Arendt‐Nielsen, B. Morlion, S. Perrot, A. Dahan, A. Dickenson, H.G. Kress, C. Wells, D. Bouhassira & A. Mohr Drewes. (2017) Assessment and manifestation of central sensitisation across different chronic pain conditions. European Journal of Pain 22:2, pages 216-241.
Crossref
Crossref
Michael Saulino. 2018. Challenging Neuropathic Pain Syndromes. Challenging Neuropathic Pain Syndromes
167
175
.
Carlos A. Guillén-Astete, César Cardona-Carballo & Cristina de la Casa-Resino. (2017) Tapentadol versus tramadol in the management of low back pain in the emergency department. Medicine 96:45, pages e8403.
Crossref
Crossref
Edvina Galiè, Veronica Villani, Irene Terrenato & Andrea Pace. (2017) Tapentadol in neuropathic pain cancer patients: a prospective open label study. Neurological Sciences 38:10, pages 1747-1752.
Crossref
Crossref
Antonella Paladini, Giustino Varrassi, Giuseppe Bentivegna, Sandro Carletti, Alba Piroli & Stefano Coaccioli. (2017) Palmitoylethanolamide in the Treatment of Failed Back Surgery Syndrome. Pain Research and Treatment 2017, pages 1-6.
Crossref
Crossref
Ralf Baron, Leopold Eberhart, Kai-Uwe Kern, Stefan Regner, Roman Rolke, Christian Simanski & Thomas Tölle. (2017) Tapentadol Prolonged Release for Chronic Pain: A Review of Clinical Trials and 5 Years of Routine Clinical Practice Data. Pain Practice 17:5, pages 678-700.
Crossref
Crossref
Eva Widerström-Noga. (2017) Neuropathic Pain and Spinal Cord Injury: Phenotypes and Pharmacological Management. Drugs 77:9, pages 967-984.
Crossref
Crossref
Andy Wolff, Revan Kumar Joshi, Jörgen Ekström, Doron Aframian, Anne Marie Lynge Pedersen, Gordon Proctor, Nagamani Narayana, Alessandro Villa, Ying Wai Sia, Ardita Aliko, Richard McGowan, Alexander Ross Kerr, Siri Beier Jensen, Arjan Vissink & Colin Dawes. (2016) A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI. Drugs in R&D 17:1, pages 1-28.
Crossref
Crossref
M. Reimer, P. Hüllemann, M. Hukauf, T. Keller, A. Binder, J. Gierthmühlen & R. Baron. (2017) Prediction of response to tapentadol in chronic low back pain. European Journal of Pain 21:2, pages 322-333.
Crossref
Crossref
Robert R. Edwards, Robert H. Dworkin, Dennis C. Turk, Martin S. Angst, Raymond Dionne, Roy Freeman, Per Hansson, Simon Haroutounian, Lars Arendt-Nielsen, Nadine Attal, Ralf Baron, Joanna Brell, Shay Bujanover, Laurie B. Burke, Daniel Carr, Amy S. Chappell, Penney Cowan, Mila Etropolski, Roger B. Fillingim, Jennifer S. Gewandter, Nathaniel P. Katz, Ernest A. Kopecky, John D. Markman, George Nomikos, Linda Porter, Bob A. Rappaport, Andrew S.C. Rice, Joseph M. Scavone, Joachim Scholz, Lee S. Simon, Shannon M. Smith, Jeffrey Tobias, Tina Tockarshewsky, Christine Veasley, Mark Versavel, Ajay D. Wasan, Warren Wen & David Yarnitsky. (2016) Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations. Pain 157:9, pages 1851-1871.
Crossref
Crossref
Michael Saulino & Justin F. Averna. (2016) Evaluation and Management of SCI-Associated Pain. Current Pain and Headache Reports 20:9.
Crossref
Crossref
A Villa, A Wolff, N Narayana, C Dawes, DJ Aframian, AM Lynge Pedersen, A Vissink, A Aliko, YW Sia, RK Joshi, R McGowan, SB Jensen, AR Kerr, J Ekström & G Proctor. (2016) World Workshop on Oral Medicine VI: a systematic review of medication-induced salivary gland dysfunction. Oral Diseases 22:5, pages 365-382.
Crossref
Crossref
R. Baron, A. Binder, N. Attal, R. Casale, A.H. Dickenson & R‐D. Treede. (2016) Neuropathic low back pain in clinical practice. European Journal of Pain 20:6, pages 861-873.
Crossref
Crossref
Ralf Baron, Jan‐Peter Jansen, Andreas Binder, Manuel Pombo‐Suarez, Lieven Kennes, Matthias Müller, Dietmar Falke & Ilona Steigerwald. (2015)
Tolerability, Safety, and Quality of Life with Tapentadol Prolonged Release (
PR
) Compared with Oxycodone/Naloxone
PR
in Patients with Severe Chronic Low Back Pain with a Neuropathic Component: A Randomized, Controlled, Open‐label, Phase 3b/4 Trial
. Pain Practice 16:5, pages 600-619.
Crossref
Crossref
Ralf Baron, Rudolf Likar, Emilio Martin‐Mola, Francisco J. Blanco, Lieven Kennes, Matthias Müller, Dietmar Falke & Ilona Steigerwald. (2015)
Effectiveness of Tapentadol Prolonged Release (
PR
) Compared with Oxycodone/Naloxone
PR
for the Management of Severe Chronic Low Back Pain with a Neuropathic Component: A Randomized, Controlled, Open‐Label, Phase 3b/4 Study
. Pain Practice 16:5, pages 580-599.
Crossref
Crossref
Eva Widerström-NogaElizabeth R. FelixJames P. AdcockMaydelis EscalonaJacqueline Tibbett. (2016) Multidimensional Neuropathic Pain Phenotypes after Spinal Cord Injury. Journal of Neurotrauma 33:5, pages 482-492.
Crossref
Crossref
Regina P. SchukroMatthias J. OehmkeAngelika GeroldingerGeorg HeinzeHans-Georg KressSibylle Pramhas. (2016) Efficacy of Duloxetine in Chronic Low Back Pain with a Neuropathic Component. Anesthesiology 124:1, pages 150-158.
Crossref
Crossref
Ralf Baron, Emilio Martin‐Mola, Matthias Müller, Cecile Dubois, Dietmar Falke & Ilona Steigerwald. (2014)
Effectiveness and Safety of Tapentadol Prolonged Release (
PR
) Versus a Combination of Tapentadol
PR
and Pregabalin for the Management of Severe, Chronic Low Back Pain With a Neuropathic Component: A Randomized, Double‐blind, Phase 3b Study
. Pain Practice 15:5, pages 455-470.
Crossref
Crossref
Ralf Baron, Uwe Kern, Matthias Müller, Cecile Dubois, Dietmar Falke & Ilona Steigerwald. (2014) Effectiveness and Tolerability of a Moderate Dose of Tapentadol Prolonged Release for Managing Severe, Chronic Low Back Pain with a Neuropathic Component: An Open‐label Continuation Arm of a Randomized Phase 3b Study. Pain Practice 15:5, pages 471-486.
Crossref
Crossref
Boaz G. Samolsky Dekel, Sivia Ghedini, Alberto Gori, Alessio Vasarri, GianFranco Di Nino & Rita M. Melotti. (2015) Lasting Prolonged-Release Tapentadol for Moderate/Severe Non-Cancer Musculoskeletal Chronic Pain. Pain and Therapy 4:1, pages 107-117.
Crossref
Crossref
Thomas Lange, Doris Krings & Susanne Waldmann-Rex. (2015) Praxisdaten zur Behandlung starker chronischer Schmerzen mit Tapentadol retardClinical practice data regarding tapentadol prolonged release treatment for severe chronic pain – improvement of analgesia, functional competence and quality of life in particular under tapentadol monotherapy. MMW - Fortschritte der Medizin 157:S4, pages 12-21.
Crossref
Crossref
Sherwyn Schwartz, Mila S. Etropolski, Douglas Y. Shapiro, Christine Rauschkolb, Aaron I. Vinik, Bernd Lange, Kimberly Cooper, Ilse Van Hove & Juergen Haeussler. (2014) A Pooled Analysis Evaluating the Efficacy and Tolerability of Tapentadol Extended Release for Chronic, Painful Diabetic Peripheral Neuropathy. Clinical Drug Investigation 35:2, pages 95-108.
Crossref
Crossref
SM Helfert, M Reimer, J Höper & R Baron. (2015) Individualized Pharmacological Treatment of Neuropathic Pain. Clinical Pharmacology & Therapeutics 97:2, pages 135-142.
Crossref
Crossref
Manuel J. Sánchez del Águila, Michael Schenk, Kai-Uwe Kern, Tanja Drost & Ilona Steigerwald. (2015) Practical Considerations for the Use of Tapentadol Prolonged Release for the Management of Severe Chronic Pain. Clinical Therapeutics 37:1, pages 94-113.
Crossref
Crossref
Aaron I. Vinik, Douglas Y. Shapiro, Christine Rauschkolb, Bernd Lange, Keith Karcher, Deborah Pennett & Mila S. Etropolski. (2014) A Randomized Withdrawal, Placebo-Controlled Study Evaluating the Efficacy and Tolerability of Tapentadol Extended Release in Patients With Chronic Painful Diabetic Peripheral Neuropathy. Diabetes Care 37:8, pages 2302-2309.
Crossref
Crossref
M. Niesters, P.L. Proto, L. Aarts, E.Y. Sarton, A.M. Drewes & A. Dahan. (2014) Tapentadol potentiates descending pain inhibition in chronic pain patients with diabetic polyneuropathy. British Journal of Anaesthesia 113:1, pages 148-156.
Crossref
Crossref
Keiichiro Imanaka, Yushin Tominaga, Mila Etropolski, Hiroki Ohashi, Keiichiro Hirose & Taka Matsumura. (2014) Ready Conversion of Patients with Well-Controlled, Moderate to Severe, Chronic Malignant Tumor–related Pain on Other Opioids to Tapentadol Extended Release. Clinical Drug Investigation 34:7, pages 501-511.
Crossref
Crossref
Matthew Thakur, Anthony H. Dickenson & Ralf Baron. (2014) Osteoarthritis pain: nociceptive or neuropathic?. Nature Reviews Rheumatology 10:6, pages 374-380.
Crossref
Crossref
Rainer Sabatowski, Rüdiger Scharnagel, Anne Gyllensvärd & Ilona Steigerwald. (2014) Driving Ability in Patients with Severe Chronic Low Back or Osteoarthritis Knee Pain on Stable Treatment with Tapentadol Prolonged Release: A Multicenter, Open-label, Phase 3b Trial. Pain and Therapy 3:1, pages 17-29.
Crossref
Crossref
G. P. Jones & S. S. Tripathi. (2014) Successful use of stellate ganglion block and a new centrally acting analgesic with dual mode of action in a resistant temporomandibular joint pain. Case Reports 2014:may20 1, pages bcr2013203308-bcr2013203308.
Crossref
Crossref
Charity Hoffelt & Andrew Zwack. (2014) Assessment and management of chronic pain in patients with depression and anxiety. Mental Health Clinician 4:3, pages 146-152.
Crossref
Crossref
Michael Saulino. (2014) Spinal Cord Injury Pain. Physical Medicine and Rehabilitation Clinics of North America 25:2, pages 397-410.
Crossref
Crossref
Ferdi Yavuz. (2014) Diagnosis and pharmacologic management of neuropathic pain among patients with chronic low back pain. World Journal of Rheumatology 4:3, pages 54.
Crossref
Crossref
he. (2013) Starke Wirksamkeit bei Schmerz. Der Hausarzt 50:10, pages 59-59.
Crossref
Crossref
K.-U. Kern, P. Bialas & D. Fangmann. (2013) Retardiertes Tapentadol bei PhantomschmerzenProlonged-release tapentadol for phantom pain. Der Schmerz 27:2, pages 174-181.
Crossref
Crossref
Rafael Gálvez, Michael Schäfer, Guy Hans, Dietmar Falke & Ilona Steigerwald. (2013) Tapentadol Prolonged Release Versus Strong Opioids for Severe, Chronic Low Back Pain: Results of an Open-Label, Phase 3b Study. Advances in Therapy 30:3, pages 229-259.
Crossref
Crossref
Stephen Bruehl, A. Vania Apkarian, Jane C. Ballantyne, Ann Berger, David Borsook, Wen G. Chen, John T. Farrar, Jennifer A. Haythornthwaite, Susan D. Horn, Michael J. Iadarola, Charles E. Inturrisi, Lixing Lao, Sean Mackey, Jianren Mao, Andrea Sawczuk, George R. Uhl, James Witter, Clifford J. Woolf, Jon-Kar Zubieta & Yu Lin. (2013) Personalized Medicine and Opioid Analgesic Prescribing for Chronic Pain: Opportunities and Challenges. The Journal of Pain 14:2, pages 103-113.
Crossref
Crossref
Robert Taylor, Joseph V. Pergolizzi & Robert B. Raffa. (2013) Tapentadol Extended Release for Chronic Pain Patients. Advances in Therapy 30:1, pages 14-27.
Crossref
Crossref